Fact CheckerSign in

NCT04321200Completed

PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

Source: ClinicalTrials.gov · Last updated 10 Aug 2026

Brief summary (registry, in English)

Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state of the art sensors combined with machine learning algorithms to develop objective, accurate, easy-to-use tools for the early scoring of deficits and lays the foundation for the early prediction of physical disability.

Status (registry)
Completed
Study type
Observational
Enrollment
166 (actual)
First submitted
17 Dec 2019
Start date
1 Nov 2020
Primary completion date
27 Oct 2025
Lead sponsor
University of Pennsylvania
NCT number
NCT04321200

What you commit to

  • Study type: Observational
  • Participants enrolled: 166
  • From 1 Nov 2020 to the primary completion date, 27 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Infants, male and female, between 0-6 months (Infants older than 6 months before initial enrollment will be excluded).
  • Infants with early brain injury (EBI):
    • Hydrocephalus
    • Hypoxic-ischemic encephalopathy (HIE)
    • Periventricular leukomalacia (PVL)
    • Intraventricular hemorrhage (IVH)
    • Stroke
  • Healthy infants (controls):
    • o No history of early brain injury (EBI)
  • Infants without EBI/risk for future disability:
    • Infants without known brain injuries, but with a history of preterm birth less than 32-week gestation with significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.

Age in the registry: 0 months to 6 months · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Childrens Hospital of Philadelphia
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.